Vitamin D Deficiency in Adults Following a Major Burn Injury
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is a single site double blind randomized controlled trial of replacing Vitamin D for
Vitamin D-deficient burn patients at a current recommended dose (400 IU daily) versus a
higher dose (4000 IU daily). Capsules will be made in a compounding pharmacy and will look
identical.
Randomized controlled trial. People who meet the selection criteria will be randomized to
either low or high dosage of Vitamin D. Treatment arm is high dose Vitamin D (4000 IU), and
control is low dose Vitamin D (400 IU). Main outcome variables include PROMIS-29 measures of
physical health, mental health and social health, the Veterans RAND 12 Item Health Survey
(VR-12), and the 4-D Itch Scale. Secondary outcome variables include subject demographics,
injury demographics and characteristics.